AgomAb Therapeutics N.V. American Shares

AGMB | NASDAQ

$7.49

-$0.46 (-5.79%)

At close: Oct 30, 2026, 4:00 PM ET

$7.49

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q4 2024 Dec 31, 2024
PE Ratio	n/a	-15.78	-16.64	-43.67
PEG Ratio	n/a	0.97	n/a	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	n/a	4.64	3.61	2.73
P/FCF Ratio	n/a	-22.66	-20.06	-40.05
P/OCF Ratio	n/a	-22.67	-20.34	-41.22
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	0.01	0.01	0.01
Quick Ratio	12.88	6.52	13.99	19.05
Current Ratio	12.88	6.52	13.99	19.05
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	-123.83	n/a
Return on Equity	n/a	-13.29%	-12.44%	-6.24%
Return on Assets	n/a	-11.32%	-11.04%	-5.69%
Return on Invested Capital	n/a	-12.21%	-9.82%	-5.98%
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a